• Home
  • Publications
  • Preclinical Validation of Tumor-Penetrating and Interfering Peptides against Chronic Lymphocytic Leukemia.
Monday, 26 December 2022 02:13

Preclinical Validation of Tumor-Penetrating and Interfering Peptides against Chronic Lymphocytic Leukemia.

Simón-Gracia L, Loisel S, Sidorenko V, Scodeller P, Parizot C, Savier E, Haute T, Teesalu T, Rebollo A. Mol Pharm. 2022 Mar 7;19(3):895-903. doi: 10.1021/acs.molpharmaceut.1c00837. Epub 2022 Feb 3. PMID: 35113575
back to top

Web by Redwall